Skip to search.
 TSX Down 0.60% TSX Ventures Down 1.08%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
47.50 Down 0.15(0.31%) Jul 6, 4:00PM EDT
Add to Portfolio
Prev Close:47.65
Open:47.27
Bid:36.98 x 100
Ask:N/A
1y Target Est:45.38
Beta:2.83
Next Earnings Date:30-Jul-15SGEN Earnings announcement
Day's Range:46.61 - 48.65
52wk Range:30.05 - 49.84
Volume:2,288,519
Avg Vol (3m):1,021,730
Market Cap:5.93B
P/E (ttm):N/A
EPS (ttm):-0.66
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SGENDown 0.31%5.93B
IMGNUp 2.78%1.24B
PFEDown 0.36%204.74B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.84
Quarterly EPS Est (Jun-15) :-0.26
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-3.27

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback